Poland· PL-100070078
Venescin
A hippocastani semen product containing hippocastani seminis extractum siccum + rutosidum + esculinum, registered in Poland by Wrocławskie Zakłady Zielarskie "Herbapol" S.A.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Hippocastani semen is registered in 7 of 19 countries.
Countries holding a registration under ATC C05CX03 (hippocastani semen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Hippocastani semen · ATC C05CX03
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Hippocastani seminis extractum siccum + Rutosidum + Esculinum
- Manufacturer
- Wrocławskie Zakłady Zielarskie "Herbapol" S.A.
- Country
- Poland (PL)
- ATC code
- C05CX03
- ATC class
- Hippocastani semen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990080410
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C05CX03
Hippocastani semen, as other registers publish it.
- NetherlandsA. Vogel Aesculaforce tablettenA.Vogel B.V.
- DenmarkAesculaforce forteA. Vogel Danmark A/S
- SwitzerlandAesculaforce forte Venen, FilmtablettenA.Vogel AG
- SwitzerlandAesculaforce forte Venen, FilmtablettenA.Vogel AG
- SwitzerlandAesculaforce forte Venen, FilmtablettenA.Vogel AG
- SwitzerlandAesculaforce forte Venen, FilmtablettenA.Vogel AG
- SwitzerlandAesculamed forte Venen
- SwitzerlandAesculamed forte Venen
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9d24be02-9417-47be-8ad7-dcffad9d029d GET /v1/drugs/9d24be02-9417-47be-8ad7-dcffad9d029d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki drażowane",
"source": "urpl",
"strength": "25 mg + 15 mg + 0,5 mg",
"packaging": "05909990080410 ¦ OTC ¦ 10527\n30 tabl.",
"substance": "Hippocastani seminis extractum (5,5-8:1) (ekstrahent 70% v/v) 25 mg + Rutosidum trihydricum 15 mg + Esculinum 500 mcg",
"common_name": "Hippocastani seminis extractum siccum + Rutosidum + Esculinum",
"pl_product_id": "100070078",
"pozwolenie_nr": "00804",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about hippocastani semen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.